Published in Retrovirology on January 25, 2010
Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells. Gene Ther (2012) 0.99
Immunogenicity of targeted lentivectors. Oncotarget (2014) 0.86
Specific targeting of human interleukin (IL)-13 receptor α2-positive cells with lentiviral vectors displaying IL-13. Hum Gene Ther Methods (2012) 0.83
Preferential lentiviral targeting of astrocytes in the central nervous system. PLoS One (2013) 0.78
Antigen-presenting cell-targeted lentiviral vectors do not support the development of productive T-cell effector responses: implications for in vivo targeted vaccine delivery. Gene Ther (2017) 0.75
A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell (1993) 4.97
Engineering targeted viral vectors for gene therapy. Nat Rev Genet (2007) 3.69
Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol (1998) 3.51
Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc (2009) 3.21
CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell (1996) 2.51
Targeted cell entry of lentiviral vectors. Mol Ther (2008) 2.34
Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther (2005) 2.21
Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat Biotechnol (2008) 2.05
The membrane-proximal stem region of vesicular stomatitis virus G protein confers efficient virus assembly. J Virol (2000) 1.96
Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat Med (2005) 1.93
Deduced consensus sequence of Sindbis virus strain AR339: mutations contained in laboratory strains which affect cell culture and in vivo phenotypes. J Virol (1996) 1.88
Targeting lentiviral vectors to specific cell types in vivo. Proc Natl Acad Sci U S A (2006) 1.71
Low pH is required for avian sarcoma and leukosis virus Env-induced hemifusion and fusion pore formation but not for pore growth. J Virol (2004) 1.52
Antibody-directed targeting of retroviral vectors via cell surface antigens. J Virol (2001) 1.50
Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types. Proc Natl Acad Sci U S A (1999) 1.48
Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. Mol Ther (2002) 1.43
Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector. J Virol (2001) 1.41
The membrane-proximal domain of vesicular stomatitis virus G protein functions as a membrane fusion potentiator and can induce hemifusion. J Virol (2002) 1.32
Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins. J Virol (2004) 1.31
Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses. J Virol (2007) 1.24
Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein. Proc Natl Acad Sci U S A (1998) 1.19
A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells. Gene Ther (1997) 1.16
A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration. Mol Ther (2007) 1.13
Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev (2008) 1.11
A comparative analysis of constitutive and cell-specific promoters in the adult mouse hippocampus using lentivirus vector-mediated gene transfer. J Gene Med (2008) 1.09
A fifteen-amino-acid TVB peptide serves as a minimal soluble receptor for subgroup B avian leukosis and sarcoma viruses. J Virol (2002) 1.07
Erythropoietin structure-function relationships: high degree of sequence homology among mammals. Blood (1993) 1.05
A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide. J Gene Med (2009) 1.00
Strategies for targeting lentiviral vectors. Curr Gene Ther (2008) 0.99
Visualization of targeted transduction by engineered lentiviral vectors. Gene Ther (2008) 0.97
Transient low pH treatment enhances infection of lentiviral vector pseudotypes with a targeting Sindbis envelope. Virology (2006) 0.97
Targeting lentiviral vectors to antigen-specific immunoglobulins. Hum Gene Ther (2008) 0.96
Efficient targeted transduction of primary human endothelial cells with dual-targeted lentiviral vectors. J Gene Med (2008) 0.96
Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines. Blood (1995) 0.95
Cell type-specific targeting with sindbis pseudotyped lentiviral vectors displaying anti-CCR5 single-chain antibodies. Hum Gene Ther (2005) 0.93
Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein. J Virol (2001) 0.91
Properties of variant forms of human stem cell factor recombinantly expressed in Escherichia coli. Arch Biochem Biophys (1994) 0.91
Targeted gene delivery by intravenous injection of retroviral vectors. Cell Cycle (2005) 0.90
Receptor-induced conformational changes in the SU subunit of the avian sarcoma/leukosis virus A envelope protein: implications for fusion activation. J Virol (2005) 0.90
Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein. Virology (2002) 0.90
Redirecting lentiviral vectors by insertion of integrin-tageting peptides into envelope proteins. J Gene Med (2009) 0.89
Targeted retroviral transduction of c-kit+ hematopoietic cells using novel ligand display technology. Blood (2004) 0.89
Targeted transduction of CD34+ hematopoietic progenitor cells in nonpurified human mobilized peripheral blood mononuclear cells. J Gene Med (2009) 0.89
Engineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectors. J Biol Eng (2009) 0.87
Cellular uptake and lysosomal delivery of galactocerebrosidase tagged with the HIV Tat protein transduction domain. J Neurochem (2007) 0.86
Mutational analysis of the subgroup A avian sarcoma and leukosis virus putative fusion peptide domain. J Virol (2000) 0.85
Targeted transduction via CD4 by a lentiviral vector uses a clathrin-mediated entry pathway. J Virol (2009) 0.83
Lentiviruses with trastuzumab bound to their envelopes can target and kill prostate cancer cells. Cancer Gene Ther (2009) 0.82
Targeted gene delivery to CD117-expressing cells in vivo with lentiviral vectors co-displaying stem cell factor and a fusogenic molecule. Biotechnol Bioeng (2009) 0.81
Generation of domestic transgenic cloned kittens using lentivirus vectors. Cloning Stem Cells (2009) 0.81
Growth factor displayed on the surface of retroviral particles without manipulation of envelope proteins is biologically active and can enhance transduction. J Gene Med (2004) 0.81
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature (2010) 3.49
Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc (2009) 3.21
Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J Virol (2007) 2.46
Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther (2005) 2.21
A viral RNA structural element alters host recognition of nonself RNA. Science (2014) 1.71
TRIF and IRF-3 binding to the TNF promoter results in macrophage TNF dysregulation and steatosis induced by chronic ethanol. J Immunol (2008) 1.70
Cystic fibrosis transmembrane conductance regulator recruitment to phagosomes in neutrophils. J Innate Immun (2013) 1.63
Effects of PKR/RNase L-dependent and alternative antiviral pathways on alphavirus replication and pathogenesis. Viral Immunol (2002) 1.56
Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis. J Virol (2008) 1.48
Host responses to alphavirus infection. Immunol Rev (2008) 1.46
Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. Mol Ther (2002) 1.43
Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins. J Virol (2004) 1.31
Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Krüppel-like factor 5. J Biol Chem (2007) 1.29
A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog (2009) 1.27
Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters. J Gene Med (2005) 1.27
Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses. J Virol (2007) 1.24
Adaptation of alphaviruses to heparan sulfate: interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin. J Virol (2002) 1.19
Similarities and differences in antagonism of neuron alpha/beta interferon responses by Venezuelan equine encephalitis and Sindbis alphaviruses. J Virol (2009) 1.19
Small- to large-scale production of lentivirus vectors. Methods Mol Biol (2003) 1.16
Non-pathogenic Sindbis virus causes hemorrhagic fever in the absence of alpha/beta and gamma interferons. Virology (2007) 1.14
Sindbis virus vectors designed to express a foreign protein as a cleavable component of the viral structural polyprotein. J Virol (2003) 1.12
Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev (2008) 1.11
Heparan sulfate binding by natural eastern equine encephalitis viruses promotes neurovirulence. Proc Natl Acad Sci U S A (2011) 1.10
Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection. J Virol Methods (2009) 1.10
Type I interferon induction is correlated with attenuation of a South American eastern equine encephalitis virus strain in mice. Virology (2009) 1.10
A comparative analysis of constitutive and cell-specific promoters in the adult mouse hippocampus using lentivirus vector-mediated gene transfer. J Gene Med (2008) 1.09
Characteristics of alpha/beta interferon induction after infection of murine fibroblasts with wild-type and mutant alphaviruses. Virology (2009) 1.08
Mosquito saliva serine protease enhances dissemination of dengue virus into the mammalian host. J Virol (2013) 1.05
Stable, high-level expression of reporter proteins from improved alphavirus expression vectors to track replication and dissemination during encephalitic and arthritogenic disease. J Virol (2013) 1.05
Application of lentivirus-mediated RNAi in studying gene function in mammalian tooth development. Dev Dyn (2006) 1.03
Multifunctional RNA nanoparticles. Nano Lett (2014) 1.03
Lentiviral gene transfer into the dorsal root ganglion of adult rats. Mol Pain (2011) 1.03
Protein inhibitor of activated STAT1 interacts with and up-regulates activities of the pro-proliferative transcription factor Krüppel-like factor 5. J Biol Chem (2006) 1.02
Genetically selected stem cells from human adipose tissue express cardiac markers. Biochem Biophys Res Commun (2006) 1.02
The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus. Virology (2009) 1.01
Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study. BMC Biotechnol (2007) 1.00
Early restriction of alphavirus replication and dissemination contributes to age-dependent attenuation of systemic hyperinflammatory disease. J Gen Virol (2007) 0.97
Alpha/beta interferon inhibits cap-dependent translation of viral but not cellular mRNA by a PKR-independent mechanism. J Virol (2007) 0.96
Simplified production and concentration of HIV-1-based lentiviral vectors using HYPERFlask vessels and anion exchange membrane chromatography. BMC Biotechnol (2009) 0.91
Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer. Genet Vaccines Ther (2009) 0.89
Cellular uptake and lysosomal delivery of galactocerebrosidase tagged with the HIV Tat protein transduction domain. J Neurochem (2007) 0.86
Natural variation in the heparan sulfate binding domain of the eastern equine encephalitis virus E2 glycoprotein alters interactions with cell surfaces and virulence in mice. J Virol (2013) 0.86
Nuclear transfer of sand cat cells into enucleated domestic cat oocytes is affected by cryopreservation of donor cells. Cloning Stem Cells (2008) 0.85
Production of lentiviral vectors in protein-free media. Curr Protoc Cell Biol (2011) 0.84
Specific targeting of human interleukin (IL)-13 receptor α2-positive cells with lentiviral vectors displaying IL-13. Hum Gene Ther Methods (2012) 0.83
A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines. Mol Cancer (2007) 0.83
Stable transgene expression in tumors and metastases after transduction with lentiviral vectors based on human immunodeficiency virus type 1. Hum Gene Ther (2004) 0.82
Attenuation of Sindbis virus variants incorporating uncleaved PE2 glycoprotein is correlated with attachment to cell-surface heparan sulfate. Virology (2004) 0.82
Generation of domestic transgenic cloned kittens using lentivirus vectors. Cloning Stem Cells (2009) 0.81
Improved tagging strategy for protein identification in mammalian cells. BMC Genomics (2005) 0.80
Regulated expression of lentivirus-mediated GDNF in human bone marrow-derived mesenchymal stem cells and its neuroprotection on dopaminergic cells in vitro. PLoS One (2013) 0.79
Targeting of herpes simplex virus 1 thymidine kinase gene sequences into the OCT4 locus of human induced pluripotent stem cells. PLoS One (2013) 0.78
In vivo imaging in an ABSL-3 regional biocontainment laboratory. Pathog Dis (2014) 0.77
Mesenchymal stem cells. Methods Mol Biol (2003) 0.76
Conditional expression of interferon-gamma to enhance host responses to pulmonary bacterial infection. Pulm Pharmacol Ther (2005) 0.75
Analysis of partial recombinants in lentiviral vector preparations. Hum Gene Ther Methods (2014) 0.75
Acquired substrate preference for GAB1 protein bestows transforming activity to ERBB2 kinase lung cancer mutants. J Biol Chem (2013) 0.75
Closing the gap between viral and noninfectious arthritis. Proc Natl Acad Sci U S A (2014) 0.75
Can understanding the virulence mechanisms of RNA viruses lead us to a vaccine against eastern equine encephalitis virus and other alphaviruses? Expert Rev Vaccines (2014) 0.75
Dopaminergic trophism after intrastriatal injection of lentivirus-transferred GDNF in Parkinson rat model. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) (2003) 0.75
Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions. Emerg Infect Dis (2020) 0.75
An anti-major histocompatibility complex class I intrabody protects endothelial cells from an attack by immune mediators. Cardiovasc Res (2006) 0.75